IRCT20170315033085N4 IRCT 2018-07-29 Mashhad University of Medical Sciences letrozole and Dexametazon effect in Poly cystic ovarian syndrome patients The Effect of Letrozole and Dexamethasone on pregnancy outcome in Poly cystic ovarian syndrome patients candidate for intra uterine insemination: Randomized Clinical trial 2013-02-03 anticipated 106 Complete https://irct.ir/trial/25617 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization, Blinding description: Data was sent in form of two Group ( A and B ) to the person responsible for data analysis and analyzer wasn't not aware of the intervention. 1-2 polycystic ovarian syndrome. Intervention 1: Control group: group A received letrozole tablet ( abouraihan , Iran ) 5 mg from day 3 of menstrual cycle for 5 days .They were monitored hormonal and Sonographical on day 3 and day 12 of cycle. Ovulation was triggered with injection 5000 Iu HCG (karma, Germany ) when the dominant follicle reached 18 mm in diameter. A single IUI was performed 36 hours later. The Luteal phase was supported with the progesterone suppository ( Cyclogest, 400 mg , Actavis, UK) . pregnancy test was don 14 day later. Intervention 2: Intervention group: group B received letrozol 5 mg(Abouraihan-Iran) from 3th day of menstrual cycle for 5 days plus Dexamethazon tablet 0.5 mg (Iran hormone) for 10 days. They were monitored hormonal and Sonographical on day 3 and day 12 of cycle. Ovulation was triggered with injection 5000 Iu HCG (karma, Germany ) when the dominant follicle reached 18 mm in diameter. A single IUI was performed 36 hours later. The Luteal phase was supported with the progesterone suppository ( Cyclogest, 400 mg , Actavis, UK) . pregnancy test was don 14 day later. No - There is not a plan to make this available Justification or reason for not sharing IPD is No more information